Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05420207 · ClinicalTrials.gov registry record

Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

A clinical trial of HIV Prevention, sponsored by Elizabeth Arnold.

Completed
Registry status
69
Enrollment target
2
Study locations

NCT05420207 is a study of HIV Prevention that has completed, run by Elizabeth Arnold. The registered enrollment target is 69 participants, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05420207, a study of HIV Prevention, has completed, sponsored by Elizabeth Arnold.

COMPLETED
Registry status
69 participants
Enrollment target
2
Study locations

Study Summary

The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the future and identify the training needs of physicians. This project specifically focuses on men who have sex with men (MSM) seen in primary care settings in Texas. The main objective of this project is to examine perspectives of MSM and physicians in Texas regarding LA-PrEP, including attitudes and barriers to use and implementation by interviewing patients and physicians from the same clinical practices.

Conditions Studied

HIV Prevention

Interventions

  • OTHER No intervention

Study Locations (2)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Texas

  • Dell Medical School, UT-Austin - Austin

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2024-06-14
Est. Completion 2025-09-05

Sponsor

Elizabeth Arnold

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05420207

The ClinicalTrials.gov registry entry for NCT05420207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (82% lower). The listed sponsor is Elizabeth Arnold, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT05420207 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Texas.

Frequently Asked Questions

What is clinical trial NCT05420207 about?

NCT05420207 is a clinical study titled "Implantable Long-Acting Pre-Exposure Prophylaxis For MSM". The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the future and identify the training needs of physicians. This project specifically focuses on men who h...

What is the current status of trial NCT05420207?

This trial is currently completed. The enrollment target is 69 participants. The study started on 2024-06-14. Estimated completion is 2025-09-05.

What conditions does trial NCT05420207 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT05420207?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT05420207?

This trial is sponsored by Elizabeth Arnold, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05420207 being conducted?

This trial has 2 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Prevention

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.